Johnson & Johnson’s (JNJ) Strong Dividend Track Record and Focus on Innovation

Core Insights - Johnson & Johnson (NYSE: JNJ) is recognized as one of the 12 Reliable Dividend Stocks for Maximum Income, highlighting its strong dividend performance and stability [1] Company Overview - Johnson & Johnson operates as a global healthcare leader, primarily focusing on pharmaceuticals and medical devices, with operations divided into two segments: Innovative Medicine and MedTech [2] - The company has a rich history of over a century, known for continuous innovation and resilience, successfully navigating market changes, patent expirations, and global health crises [3] Financial Performance - In 2024, Johnson & Johnson allocated $17 billion towards research and development and distributed $118 billion in dividends, showcasing its robust cash flow and commitment to shareholder returns [4] - The company has a remarkable track record of increasing dividends for 63 consecutive years, currently offering a quarterly dividend of $1.30 per share, resulting in a dividend yield of 2.72% as of October 13 [4]